ArticleEndocrine pathology2025
MiThyCA: A Computational Pathology Pipeline for the Identification of Microscopic Foci of Papillary Thyroid Carcinoma-Like Nuclear Features with AI in Whole-Slide Histological Images.
Article in Endocrine pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating Radiomics and Computational Pathology to Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma and Uncover Its Biological Basis in Tumor Microenvironment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
The histological identification of papillary thyroid carcinoma (PTC) is straightforward for experienced endocrine pathologists. The increase in radical thyroidectomies led to a raise in the rate of postoperative incidental subcentimeter PTC foci and the recent introduction of the Non-Invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) as a less aggressive mimicker of PTC, which significantly complicated the histology screening of thyroid histology specimens. Artificial Intelligence (AI) applied to Whole Slide Images (WSI) can speed up these processes, aiding pathologists to improve diagnostic accuracy and turnaround times. Here we present a computational pathology pipeline for the identification of Microscopic foci of papillary Thyroid Carcinoma-like nuclear features using Artificial intelligence (MiThyCA). This algorithm relies on a tandem architecture consisting of a Convolutional Neural Network (CNN) designed to identify neoplastic areas within thyroid specimens, and a Vision Transformer (TinyViT) focused on detecting PTC-like areas within the neoplastic regions identified by the first model. The study was conducted on a multi-institutional cohort of 73 WSIs from 67 patients with normal thyroid tissue (n = 22 patients, 33%), NIFTP (n = 19, 28%), PTC (n = 23, 34%), and lymph nodes (n = 3, 5%). Cases were divided into training (n = 40 patients, 41 WSIs), validation (n = 13 patients, 14 WSIs) and test (n = 14 patients, 18 WSIs) sets. Each model singly demonstrated excellent performance at the tile-level on the validation set (accuracy = 0.95 and AUC-ROC = 0.95 for CNN, accuracy = 0.86 and AUC-ROC = 0.84 for TinyViT), with their tandem combination in MiThyCA showing accuracy = 0.85 and F1 score = 0.8 on the validation set at the whole WSI-level. The average total execution time of MiThyCA on the test set WSIs was 51 ± 27 s on average on workstations not equipped with GPU, and up to 16 ± 6 s and 11 ± 4 s per WSI with Nvidia GPU and Apple's laptop chip, respectively. Worthy of note, WSIs dimension did not significantly impact the algorithm processing time. Given its speed and accessibility, MiThyCA is a promising AI-based computer-aided diagnostic tool for the detection of subcentimeter PTC foci in histology.
Indexed as
Identifiers
41053275What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.